⌘K
Aptus Pharma
BSE: APPL · Pharmaceuticals
—
52W Range₹88 – ₹465
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Aptus Pharma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Start your research today
Unlock AI insights, financials, peers and live data on Aptus Pharma and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Aptus PharmaAPPL | ₹607 Cr | — | — | — | 16.0% | — | — | +331.6% |
Zim LaboratoriesZIMLAB | ₹715 Cr | 167.10 | 20.79 | 7.6% | 9.9% | 1.3% | 5.7% | +91.2% |
Valiant Laboratories LimitedVALIANTLAB | ₹658 Cr | 42.40 | 19.55 | 89.6% | 11.7% | 5.9% | 8.0% | +50.1% |
Influx Health.INFLUX | ₹655 Cr | — | — | — | 20.0% | — | — | +51.5% |
TranschemTRANSCHEM | ₹502 Cr | 75.62 | 52.99 | -100.0% | 177.7% | 8.3% | 10.6% | +600.8% |
Albert DavidALBERTDAVD | ₹501 Cr | 21.67 | 13.19 | 11.4% | 11.0% | 5.8% | 7.5% | +10.3% |
As of Mar 2026
Financials
Aptus Pharma
BSE: APPL · Pharmaceuticals
—
52W Range₹88 – ₹465
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Aptus Pharma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Start your research today
Unlock AI insights, financials, peers and live data on Aptus Pharma and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026